Medicinal Products
Explore all topics, guides, and frameworks related to Medicinal Products.
Articles in this section
10- Valsartan: Discovery, Development, Safety and Pharmacovigilance A product-lifecycle review linking valsartan's clinical evidence to pharmacovigilance, quality defects, nitrosamine recalls and risk minimisation. Read Article →
- Tafamidis: Discovery, Development, Safety and Pharmacovigilance From kinetic stabilisation of transthyretin to the Coelho and ATTR-ACT trials, regional indication differences, tafamidis/meglumine formulation distinctions, safety assessment and practical QPPV oversight. Read Article →
- Sertraline: Discovery, Development, Safety and Pharmacovigilance Sertraline's development and clinical expansion, contemporary US and UK labelling, benefit–risk interpretation, special populations, drug interactions and operational pharmacovigilance. Read Article →
- Osimertinib: Discovery, Development, Safety and Pharmacovigilance AZD9291 discovery, EGFR biology, AURA3, FLAURA, ADAURA, FLAURA2 and LAURA, 2026 US/EU product information, pulmonary, cardiac, haematological and muscular safety, and operational case assessment. Read Article →
- Enzalutamide: Discovery, Development, Safety and Pharmacovigilance MDV3100 discovery, androgen-receptor biology, AFFIRM, PREVAIL, PROSPER, ARCHES, ENZAMET and EMBARK; current US/EU authorisations; seizures, cardiovascular and fracture risks, dysphagia, digoxin assay interference and practical pharmacovigilance. Read Article →
- Escitalopram: Discovery, Development, Safety and Pharmacovigilance Development and clinical evidence for escitalopram, US and UK indications, cardiac and neuropsychiatric safety, special populations and practical PV. Read Article →
- Dexamfetamine: Discovery, Development, Safety and Pharmacovigilance A lifecycle review distinguishing dexamfetamine from racemic amfetamine, mixed salts and lisdexamfetamine, with critical interpretation of clinical trials and practical product-specific safety assessment. Read Article →
- Amfetamine: Discovery, Development, Safety and Pharmacovigilance Historical development, monoamine pharmacology, stereoisomers and formulations, current US labelling, abuse-risk communication and practical pharmacovigilance for amfetamine. Read Article →
- Omeprazole: Discovery, Development, Safety and Pharmacovigilance Trace omeprazole's discovery, proton-pump pharmacology, pivotal comparative trials, Helicobacter pylori eradication, generic and nonprescription use, clinical pharmacology, regulatory safety warnings and practical pharmacovigilance. Read Article →
- Empagliflozin: Discovery, Development, Safety and Pharmacovigilance Boehringer Ingelheim's empagliflozin development, major trials, approvals, serious risks, vulnerable populations and practical benefit–risk surveillance. Read Article →